MRNA News Archives - BioPharmaJournal

Moderna Inc. (NASDAQ: MRNA) Announce Phase 2 EPICCURE Study Results Evaluating...

Kate Hudson - November 30, 2021 0

Approval Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine In Teenagers Delayed Because...

Gavins Felicity - October 22, 2021 0

Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine Booster Under EU Review

Gavins Felicity - October 6, 2021 0

Indian Government Will Not Purchase the Pfizer Inc. (NYSE: PFE) and...

Gavins Felicity - September 27, 2021 0

Moderna Inc. (NASDAQ: MRNA) Receives New Drug Submission Approval From Health...

Gavins Felicity - September 20, 2021 0

Moderna (NASDAQ: MRNA) Reveals Plans to Create A Combined Coronavirus and...

Kate Hudson - September 13, 2021 0

Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine...

Gavins Felicity - September 6, 2021 0

Moderna Inc. (NASDAQ: MRNA) Vaccine Distribution Suspended In Japan Following Contamination...

Gavins Felicity - August 30, 2021 0

Moderna Inc.’s (NASDAQ: MRNA) and Sinopharm Group Co Vaccines Receive Emergency...

Ward Sport - August 24, 2021 0

Moderna Inc.’s (NASDAQ: MRNA) COVID19 Vaccine Manufacturing Partners Experiencing Delay Issues

Matt Wade - August 3, 2021 0

12 Page 1 of 2

Mustang Bio Inc (NASDAQ: MBIO) Receives Orphan Drug Designation From US...

Kate Hudson - July 6, 2022 0

Mustang Bio Inc (NASDAQ: MBIO) has received an Orphan Drug Designation from the US FDA for its CD20-targeted, autologous CAR T cell therapy, MB-106,...

CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...

July 5, 2022

Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA

July 4, 2022

Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...

July 1, 2022

Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...

June 30, 2022

Tag: MRNA News

Recent Post